Latest Update FDA - Search News

FDA updates recall for granola bars sold nationwide

‘May contain metal pieces’: FDA updates recall for granola bars sold nationwide

The U.S. Food and Drug Administration has posted an update on a granola bar recall initiated last year, labeling it as “Class II” — meaning the recalled product "may cause temporary or medically reversible adverse health consequences.

Newsweek on MSN · 2d

Pretzel Recall Update as FDA Sets Highest Risk Level'

Consuming the recalled pretzels if you have a milk allergy could cause "serious adverse health consequences or death."

WTVO on MSN · 3d

FDA upgrades severity of granola bar recall

The Food and Drug Administration (FDA) is warning consumers to not buy multiple types of granola bars. The bars were upgraded to class 2, which means consuming the granola could cause

People’s Pharmacy: Here’s the latest FDA update on breast implant illness

The safety of breast implants has been controversial for decades. On February 6, 2025, the Food and Drug Administration ...

Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for the treatment of ...

JD Supra6d

FDA Publishes Rule Updating ‘Healthy’ Nutrient Content Claim

On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...

Today2d

Granola bar recall: FDA updates recall for over 2 million MadeGood granola bars

The U.S. Food and Drug Administration has made an update to its MadeGood granola bar ... On Feb. 11, the FDA classified the recall as Class II. Per the FDA, a Class II classification is given ...

FiercePharma5d

Astellas' eye med Izervay lands key FDA label update, amping up market battle with Apellis rival

In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...

UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Morningstar7d

PharmaTher Provides Update on FDA New Drug Application for Ketamine

The FDA requested new and updated information and ... and Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results